-
公开(公告)号:KR1020100064516A
公开(公告)日:2010-06-15
申请号:KR1020080122995
申请日:2008-12-05
Applicant: 서울대학교산학협력단
IPC: A61K31/7105 , A61P35/00
CPC classification number: A61K31/7105
Abstract: PURPOSE: An anticancer agent containing miRNA is provided to induce apoptosis of cancer cells and to treat cancer. CONSTITUTION: An anticancer agent contains miR-29 as an active ingredient. The miR-29 is miR-29a, miR-29b, or miR-29c miRNA. The miR-29a, miR-29b, and miR-29c have a nucleotide of sequence number 149, 150, and 152, respectively. The anticancer agent is manufactured by mixing miR-29 and pharmaceutically acceptable carrier or media.
Abstract translation: 目的:提供含有miRNA的抗癌剂以诱导癌细胞的凋亡和治疗癌症。 构成:抗癌剂含有miR-29作为活性成分。 miR-29是miR-29a,miR-29b或miR-29c miRNA。 miR-29a,miR-29b和miR-29c分别具有序列号149,150和152的核苷酸。 抗癌剂通过混合miR-29和药学上可接受的载体或介质来制备。